Close menu




November 23rd, 2022 | 10:06 CET

GreenTech takes off again: BASF, Meta Materials, Nordex, JinkoSolar - Is there a quick comeback?

  • Innovations
  • Technology
  • GreenTech
Photo credits: pixabay.com

For the rapid expansion of "renewable energies", the traffic light coalition has presented a 500-page package of measures this year. With its help, the share of alternative power generation is to be increased as quickly as possible from the current level of around 50% to about 80%. According to reports from Berlin, the necessary approval loops with authorities will be drastically shortened. However, a prerequisite for this would be the population's approval for any encroachments on property in terms of distance regulations, noise and residential quality. It is here where things are currently hitting a snag because the government's bill includes extensive encroachments on nature and major sacrifices by residents in order to serve the common good. But with no one pushing forward on this issue, skepticism about quick success is warranted. Who are the big beneficiaries of climate technology progress?

time to read: 5 minutes | Author: André Will-Laudien
ISIN: BASF SE NA O.N. | DE000BASF111 , Meta Materials Inc. | US59134N1046 , NORDEX SE O.N. | DE000A0D6554 , JINKOSOLAR ADR/4 DL-00002 | US47759T1007

Table of contents:


    BASF - Cost-cutting measures at Germany's largest chemical site

    Ludwigshafen-based chemical company BASF is one of the largest suppliers of starting materials for the GreenTech industry. Substances are produced and mixed here with high-energy input, important chemical precursors for high-tech manufacturers in the alternative energy and e-mobility sectors. But production costs are rising. Germany, as an industrial location, has been suffering from extreme inflation on the energy side since the start of the war in Ukraine. So far, there is no improvement in sight.

    Therefore, BASF is considering new sites in order to achieve extensive cost reductions across the Group. With more than half of the planned savings, the headquarters in Ludwigshafen is also affected. This is not good news for Germany's competitiveness in an international comparison since 39,000 of the total 111,000 employees worldwide work here.

    BASF - The Ludwigshafen site is dependent on gas. Source: BASF SE

    But since innovation and research are future business drivers, BASF cannot do without a large research division. The crux of the matter is that investments will probably be made abroad in the future. The management had just approved a new site for around EUR 10 billion in China. A slap in the face for German industrial policy and a medium-term loss of valuable jobs. Because of the difficult conditions in Europe, BASF's management also set up an austerity program to be implemented from 2023 to 2024. The cuts are intended to reduce annual non-production costs by a massive EUR 500 million, and the Company is not ruling out job cuts in the process.

    The Ludwigshafen headquarters is still the heart of BASF, but it is clear where the Company is headed in the medium term. From today's perspective, input costs for energy-intensive production in Asia and North America are significantly lower than in Europe, and Brussels' energy and industrial policies are not very attractive. The Group is currently benefiting from the excellent performance of its subsidiary Wintershall DEA, which could save the operating figures in 2022. BASF shares have risen strongly in 2022 to EUR 52 since the lows of around EUR 38. At currently EUR 49.50, investors are looking at a P/E ratio of just under 10, and if earnings remain unchanged, they will receive a 7% dividend on top.

    Meta Materials - A bouquet of good news

    In days of energy scarcity and increased industrial efficiencies, the focus is again on technology companies that make more efficient processes possible through their patents. At innovator Meta Materials, it is all about coatings on glass, building structures and other design elements that can be made high-tech. For example, the Company develops sensibly integrated antennas and camouflage caps for armaments. The first solutions for the booming e-mobility sector have also been available for some time. Together with its partner company Coulometrics, Meta now wants to make batteries for electric cars safer, more durable and more powerful.

    With its innovative developments, META®-Materials is thus repeatedly in the focus of the manufacturing industry. A proof-of-concept was recently presented as part of Deloitte's Canadian Technology Fast 50 program. The Nova Scotia-based company was named one of the winners in the "Clean Technology" category. The competition's category, introduced last year, recognizes Canada's best innovators whose achievements help reduce environmental impact. META's management attributes the Company's triple-digit growth to its ability to develop new functional materials with properties that go beyond what nature has already created. The nanomaterials developed address a highly dynamic market estimated to reach USD 10.7 billion by 2030. This refers to solutions for 5G networks, e-mobility, autonomous driving and much more.

    George Palikaras comments, "META continues to set new standards in terms of product performance and sustainability. We design and manufacture highly functional materials and devices that use less energy and materials and sustainably improve supply chains." Anders McKenzie, partner and national leader of the Technology Fast 50 program at Deloitte Canada sums it up: "These outstanding companies are among the elite of Canada's clean technology sector, developing and bringing to market innovations that create a more resilient and sustainable future for the environment." The current outstanding sentiment for META shares is also being spurred by insider buying. Director John Harding, for example, purchased 126,000 shares at USD 1.74. This attracts new investors, and the share price continues to rise with high trading volumes. The META share has thus already more than doubled since mid-October and conquered the USD 2.00 mark again. Well done!

    JinkoSolar and Nordex - And already things are looking up again

    The mood in the GreenTech sector is noticeably improving due to the announcements at the COP 27 climate summit, as a flood of orders is expected through the green programs of the governments concerned worldwide. At Chinese solar panel expert JinkoSolar, sales rose 130% to CNY 19.52 billion in the latest quarter, up from just CNY 8.47 billion a year earlier. This was clearly above analysts' expectations, but the good mood for the share quickly subsided again. The Company is currently still suffering from the restrictions of the government's Zero-COVID policy and expects this to impact the current quarter negatively. The share price was able to vehemently turn at the EUR 42 mark in the last 6 weeks and reached EUR 54 again, but the value is still far away from the summer high at approx. EUR 75. With the recent correction on the NASDAQ, the price fell back below EUR 47.

    Over the summer, Nordex was burdened by continuous capital increases, which repeatedly meant additional financing for long-term investors. Since the 9-month figures, however, things have been going steeply upward again. According to the board, the Company is still struggling with higher costs and interrupted supply chains, which will weigh heavily on the current year. However, with sales of EUR 1.7 billion in Q3, the group is 50% above last year, but the operating loss will still reach 4% of sales in 2022. For 2023 to 2025, however, the mood is thoroughly positive, as rising sales prices from adjusted customer contracts should have a very positive impact with a time lag. Further hope for the future is provided by the lush order situation, with the total order backlog of turbines not yet delivered and installed rising to a value of EUR 6.5 billion. That is another EUR 1.5 billion more than the order pipeline showed a year earlier. In the last 6 weeks alone, the share price has gained a good 50% and was recently able to clear the technical hurdle of EUR 11. The Hamburg-based company seems to have finally turned the corner.


    Sentiment in growth markets is improving, but high interest rates burden valuations. BASF is as solid as a rock. Nordex and JinkoSolar continue to benefit from the energy transition. Meta Materials recently received an award for its innovations, which sent the share price up by over 120%.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author



    Related comments:

    Commented by André Will-Laudien on April 24th, 2024 | 07:00 CEST

    Takeover rumors for biotech shares: BioNTech, Formycon, Cardiol Therapeutics and Novo Nordisk in focus

    • Biotechnology
    • Pharma
    • Innovations
    • Cancer

    The biotech sector has significantly lagged behind the performance of artificial intelligence and high-tech this year. This is due to high inflation, which in turn has made an imminent interest rate cut unlikely. Nevertheless, Germany's economic conditions are deteriorating dramatically, particularly due to the ongoing geopolitical conflicts. It should, therefore, come as no surprise if the ECB announces an "emergency interest rate cut" in the summer. That would then be the starting signal for a major reshuffle out of the best performers of recent months and into the long-neglected biotech segment. We have selected a few interesting stocks.

    Read

    Commented by André Will-Laudien on April 23rd, 2024 | 07:45 CEST

    Attention: DAX dividends! Car stocks pay out: Mercedes-Benz, MS Industrie, VW and BMW

    • Technology
    • hightech
    • Automotive
    • Electromobility

    The DAX 40 index has gone into reverse gear in recent weeks. In addition to the high-tech and artificial intelligence sectors, the multi-month bull market also included defense stocks in the interim phase. There is no real reason to celebrate among automotive stocks, as an expected decline in GDP also means reduced household budgets. This translates to fewer new vehicle sales, with many electric vehicles produced in bulk occupying important showroom space from dealers for months. The pain is increasing, and those looking to sell vehicles find themselves in ruinous discount battles with cheap Chinese imports. However, there appears to be a glimmer of hope on the horizon: interest rate cuts! They are expected in the second half of the year. We analyze the current situation.

    Read

    Commented by Fabian Lorenz on April 23rd, 2024 | 07:00 CEST

    TAKEOVER FEVER for biotech shares! Evotec, Bayer, Vidac Pharma - Who will follow Morphosys?

    • Biotechnology
    • Pharma
    • Innovations
    • Cancer

    There is takeover fever in the biotech sector. Genmab recently announced the acquisition of ProfoundBio, the US biotech company developing ovarian and endometrial cancer drugs, for USD 1.8 billion. With Morphosys, the takeover carousel is also turning in Germany. Who is the next candidate? Evotec is often mentioned. Due to unauthorized insider trading, the biotech company's shares have come under fire this year and offer an interesting entry opportunity. Vidac Pharma also impresses operationally. The Company's new approach has the potential to revolutionize cancer treatment. The study results of the past few months are very promising. Bayer shares surprised investors yesterday as one of the day's winners in the DAX. Is the Leverkusen-based company's stock about to take off?

    Read